KOENIG SHELDON L. (Chief Operating Officer) sold 1.2% of their position (25.58K shares) of ESPERION THERAPEUTICS, INC. on the open market
Open‑market sale worth $69.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001628280-26-019411
Officer· Chief Operating Officer
Since Dec 2020
-25.58K
Net shares
Net seller
$69.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−25.58K
Price / share
$2.72
Trade value
$69.55K
% of position
1.2%
3/17/2026
2.20M→2.17M
Total
Net shares
−25.58K
Net value
-$69.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −25.58K | $2.72 | $69.55K | 1.2% | 2.20M | 2.17M |
| Total | −25.58K | -$69.55K | ||||||
Derivative Transactions0
No derivative transactions reported